| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 715 | 758 | 766 | 754 | 789 | 832 | 614 | 891 | 1,109 | 1,262 | 1,379 | 1,398 |
| Expenses | 630 | 676 | 687 | 680 | 707 | 744 | 573 | 774 | 948 | 1,051 | 1,112 | 1,123 |
| EBITDA | 86 | 82 | 79 | 74 | 81 | 87 | 41 | 117 | 161 | 210 | 267 | 275 |
| Operating Profit % | 12 % | 11 % | 10 % | 10 % | 10 % | 10 % | 7 % | 13 % | 14 % | 16 % | 18 % | 18 % |
| Depreciation | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 | 44 |
| Interest | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 | 6 |
| Profit Before Tax | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 | 225 |
| Tax | 17 | 14 | 15 | 13 | 16 | 5 | 2 | 21 | 31 | 42 | 55 | 62 |
| Net Profit | 33 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 168 |
| EPS in ₹ | 3.54 | 2.67 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 18.30 |
Indraprastha Medical Corporation
Indraprastha Medical Corporation
556.25
+2.15
(0.39%)
Key Fundamentals
Market Cap
5,079.60 Cr
EPS
17.56
PE Ratio
30.40
Dividend Yield
0.81 %
Industry
Healthcare Services 52 Week High
624.70
52 Week Low
307.25
PB Ratio
8.54
Debt to Equity
0.06
Sector
Hospitals Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Indraprastha Medical Corporation shares reached an all-time high of Rs 624, gaining over 30% in two days and nearly 40% over five trading sessions. The rally follows the Central Government Health Services announcing its biggest tariff revision in 15 years, increasing package rates for nearly 2,000 medical procedures by 5-30%, particularly benefiting specialties like orthopaedics, cardiology, and oncology. The company, a joint venture between Apollo Hospitals and Delhi government, expects higher CGHS-linked revenues and improved average revenue per occupied bed from the tariff hike. The stock has gained 15% year-to-date and 44% over 12 months, though it's trading with an RSI of 82, indicating potential overbought conditions.
Indraprastha Medical Corporation Reports Q1 Results and Key Board AppointmentsAug 06, 2025
Indraprastha Medical Corporation Limited approved its unaudited financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 365.06 crore compared to Rs 347.86 crore in the same quarter last year, with profit after tax increasing to Rs 51.46 crore from Rs 44.77 crore year-on-year. Earnings per share stood at Rs 5.61 versus Rs 4.88 in the previous year quarter. The Board appointed Mr. Sudhir Jalan as an Independent Director for a five-year term from August 6, 2025 to August 5, 2030, subject to shareholder approval. The company scheduled its 37th Annual General Meeting for September 24, 2025, and fixed the record date as September 18, 2025 for dividend entitlement for 2024-25. Additionally, the Board re-appointed M/s Devarajan Swaminathan and Co. as Cost Auditors for 2025-26 and appointed M/s RSM & Co. as Secretarial Auditors for five years from 2025-26 to 2029-30, both subject to shareholder approval.
Indraprastha Medical Corp reported Q1 EBITDA of 726 million rupees compared to 680 million rupees in the same period last year. The company's EBITDA margin improved to 19.89% from 19.54% year-over-year. Net profit increased to 515 million rupees from 448 million rupees in the previous year's corresponding quarter. Revenue grew to 3.7 billion rupees compared to 3.5 billion rupees year-over-year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,202.70 | #1 1,14,266.90 | 101.89 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 60.77 | |
7,901.50 | 1,12,633.70 | 69.74 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 64.47 | |
1,084.90 | 82,686.80 | 90.81 | 7,849.70 | 13.25 | 809 | #1 53.33 | 68.38 | |
1,371.70 | 37,523.10 | 69.05 | 3,771.40 | 12.59 | 481 | 49.58 | 53.54 | |
702.45 | 36,234.80 | 104.27 | 4,286.70 | 15.12 | 337 | -98.18 | 65.62 | |
1,755.40 | 36,063.60 | #1 45.68 | 5,575.00 | 12.29 | 790 | -2.38 | 47.19 | |
719.90 | 29,362.20 | 71.28 | 3,067.00 | 21.98 | 415 | -10.71 | 49.37 | |
1,348.80 | 13,375.30 | 53.04 | 1,566.90 | 17.46 | 244 | 35.52 | 41.78 | |
1,544.00 | 10,034.20 | 52.47 | 1,290.20 | 17.77 | 194 | -1.57 | 59.98 | |
733.55 | 10,001.10 | 250.98 | 2,257.70 | 17.03 | 49 | -55.88 | 71.60 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
9.31 %
Net Income Growth
29.84 %
Cash Flow Change
-21.68 %
ROE
3.97 %
ROCE
8.42 %
EBITDA Margin (Avg.)
16.14 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 |
| Fixed Assets | 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 |
| Current Assets | 149 | 152 | 158 | 133 | 136 | 142 | 141 | 157 | 223 | 308 | 431 |
| Capital Work in Progress | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 1 | 33 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 |
| Total Liabilities | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 |
| Current Liabilities | 194 | 191 | 186 | 138 | 124 | 140 | 116 | 94 | 130 | 165 | 179 |
| Non Current Liabilities | 53 | 46 | 42 | 62 | 54 | 42 | 43 | 43 | 46 | 80 | 76 |
| Total Equity | 195 | 224 | 231 | 232 | 244 | 268 | 273 | 325 | 380 | 478 | 597 |
| Reserve & Surplus | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 |
| Share Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -1 | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 |
| Investing Activities | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 |
| Operating Activities | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 145 | 200 | 157 |
| Financing Activities | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % | 51.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.80 % | 0.00 % | 1.08 % | 1.70 % | 2.64 % | 2.88 % | 2.94 % | 2.72 % | 2.41 % |
| DIIs | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.00 % | 0.00 % | 0.00 % | 6.71 % | 6.36 % | 4.91 % | 3.15 % | 3.20 % | 3.19 % | 3.56 % | 3.56 % | 3.51 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.88 % | 30.89 % | 32.22 % | 31.79 % | 31.60 % | 31.40 % | 31.25 % | 30.11 % | 29.66 % | 29.31 % | 28.94 % | 29.32 % | 29.58 % | 30.18 % | 30.11 % | 30.44 % | 29.97 % | 29.87 % | 30.08 % |
| Others | 19.10 % | 18.09 % | 16.76 % | 17.19 % | 17.39 % | 17.59 % | 17.73 % | 18.89 % | 19.34 % | 19.68 % | 12.55 % | 13.32 % | 13.43 % | 13.98 % | 13.05 % | 12.49 % | 12.53 % | 12.85 % | 13.00 % |
| No of Share Holders | 44,840 | 59,093 | 58,001 | 57,254 | 56,540 | 55,290 | 55,287 | 52,760 | 49,833 | 48,630 | 47,865 | 51,448 | 54,158 | 55,103 | 64,671 | 69,697 | 70,491 | 70,211 | 70,914 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3 | 4.5 | 4.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.75 | 1.17 | 0.81 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Nov 2025 |  Quarterly Result Announcement | NA | 01 Nov 2025 | 554.05 | 556.00 |
| 17 Sept 2022 |  Dividend | ₹ 2.50 /share | 15 Sept 2022 | 57.40 | 68.30 |
| 16 Sept 2023 | Dividend | ₹ 3.00 /share | 15 Sept 2023 | 84.00 | 161.50 |
| 14 Sept 2024 | Dividend | ₹ 4.50 /share | 13 Sept 2024 | 245.60 | 478.90 |
| 24 Sept 2024 |  Annual General Meeting | NA | 24 Sept 2024 | 267.70 | 449.25 |
| 30 Oct 2024 | Quarterly Result Announcement | NA | 30 Oct 2024 | 423.80 | 419.80 |
| 03 Feb 2025 | Quarterly Result Announcement | NA | 03 Feb 2025 | 477.90 | 481.20 |
| 16 May 2025 | Quarterly Result Announcement | NA | 16 May 2025 | 394.20 | 423.40 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 476.10 | 447.10 |
| 18 Sept 2025 | Dividend | ₹ 4.50 /share | 18 Sept 2025 | 409.60 | 480.65 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 447.10 | 461.80 |
Announcements
Board Meeting Intimation for To Consider And Approve Un-Audited Financial Results For Quarter Ended 30Th September 2025.
2 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
6 days agoRumour verification - Regulation 30(11)10 days ago
10 days agoClarification Sought from Indraprastha Medical Corporation LtdOct 08, 2025
Oct 08, 2025Rumour verification - Regulation 30(11)Oct 08, 2025
Oct 08, 2025Clarification sought from Indraprastha Medical Corporation LtdOct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025AGM On 24Th September 2025Sep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Annual General Meeting On 24Th September 2025Aug 06, 2025
Aug 06, 2025Corporate Action- Record Date For Dividend For The Year 2024-25Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Aug 06, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Board Meeting On 6Th August 2025Jul 22, 2025
Jul 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Jul 12, 2025Closure of Trading WindowJun 20, 2025
Jun 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 23, 2025
May 23, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
May 17, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 16, 2025
May 16, 2025Board Meeting Intimation for Board Meeting On 16Th May 2025May 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 28, 2025
Apr 28, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Apr 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Apr 09, 2025Closure of Trading WindowMar 24, 2025
Mar 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2025
Feb 04, 2025Integrated Filing (Financial)Feb 04, 2025
Feb 04, 2025Unaudited Financial Results For The Quarter Ended 31St December 2024Feb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Feb 01, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 31, 2025
Jan 31, 2025Board Meeting Intimation for Board Meeting To Consider And Approve Unaudited Financial Results For The Quarter Ended 31St December 2024Jan 21, 2025
Jan 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025
Jan 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Jan 09, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 06, 2025
Jan 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2024
Nov 07, 2024General AnnouncementNov 01, 2024
Nov 01, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2024
Oct 31, 2024RESULTS FOR THE QUATERENDD 30TH SEPTEMBER,2024Oct 30, 2024
Oct 30, 2024Board Meeting Intimation for Board Meeting On 30Th October, 2024Oct 21, 2024
Oct 21, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Oct 15, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 27, 2024
Sep 27, 2024Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.15% | -18 | 0.00% | 0.00% | |
 Motilal Oswal Quant Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Quant Small Cap Fund Direct Plan-Growth | 0.36% | 0 | 0.00% | -0.02% |
Technical Indicators
RSI(14)
Neutral 65.51
ATR(14)
Less Volatile 25.64
STOCH(9,6)
Neutral 64.19
STOCH RSI(14)
Neutral 71.44
MACD(12,26)
Bullish 6.04
ADX(14)
Strong Trend 38.59
UO(9)
Bearish 52.01
ROC(12)
Uptrend And Accelerating 25.06
WillR(14)
Neutral -36.73
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
